Fruzzetti: You have to be disciplined around valuation heading into the end of the year

Key Concepts

• Discipline: Emphasized as a crucial investment principle, particularly concerning valuation.
• Valuation: A primary consideration for investment decisions, especially as the year concludes.
• Momentum: Acknowledged as a driving force in markets, but cautioned against letting it override fundamental analysis.
• Agilent Technologies (A"): A healthcare technology company identified as a stock pick.
• Midterm Election Cycles: Historical data suggests healthcare sector outperformance during these periods.
• US-China Trade Relations: Potential improvements are seen as beneficial for companies impacted by tariffs and logistics costs.
• Government Shutdown: Anticipated to end, leading to increased procedures and economic activity.
• Labor Market/Health Insurance: A stronger labor market with more insured individuals can boost healthcare demand.
• Gold: Recommended as a core portfolio holding for balance, despite recent rallies.
• Dollar Strength: A rising dollar could negatively impact future earnings, but downward pressure is expected long-term due to deficit issues.
• Earnings Season: Strong earnings from tech giants like Amazon and Apple are noted.

Investment Strategy and Market Outlook

The discussion centers on the importance of discipline in investing, particularly regarding valuation as the year draws to a close. While momentum is recognized as a significant market driver, the speaker advocates for a disciplined approach that considers fundamental value.

Agilent Technologies (A") - A Healthcare Tech Pick

• Company Profile: Agilent Technologies is presented as a compelling investment. Its core business involves equipment that analyzes a wide range of substances, including chemicals, food, water, cancer cells, and semiconductors. This equipment is utilized in diverse settings such as hospitals, pharmaceutical facilities, and research laboratories.
• Revenue Model: A significant portion of Agilent's revenue is derived from its service model, which is highlighted as an interesting aspect of its business.
• Sectoral Outperformance: The pick is further justified by historical trends. Going back 11 out of the last 13 midterm election cycles, the healthcare sector has historically outperformed the broader market. Agilent, being a healthcare technology company, is positioned to benefit from this trend heading into 2026, which is a midterm election year.

Factors Influencing Agilent's Performance

The speaker acknowledges that Agilent's performance is intertwined with several macroeconomic and geopolitical factors:

• US-China Trade Relations: Improvements in US-China trade relations are seen as a positive catalyst, as Agilent has been significantly affected by tariffs and increased logistics costs.
• Government Shutdown: The anticipated end of the government shutdown is expected to lead to an increase in medical procedures, thereby benefiting Agilent's business.
• Labor Market and Health Insurance: A robust labor market, leading to more individuals having health insurance, is likely to drive demand for operations and other healthcare services, positively impacting Agilent.

While not explicitly stating bullishness on all these factors, the speaker confirms that improvements in these areas contribute to the positive outlook for Agilent. The company's year-to-date performance has been modest, with a gain of approximately 6-7%.

Gold as a Core Holding

• Jeff Gundlach's View: The discussion references Jeff Gundlach's recent suggestion to reduce gold holdings.
• Speaker's Perspective: In contrast, the speaker maintains a positive stance on gold, recommending it as a core holding for portfolio balance. Despite its significant rally year-to-date, gold is considered underowned by most retail investors. The speaker believes it should remain a fundamental part of any investment portfolio.

Earnings Season and the US Dollar

• Strong Earnings Reports: The market has seen positive movement driven by strong earnings from major companies like Amazon and Apple.
• Impact of Dollar Strength: A notable aspect of the current earnings season is the rise in the US dollar, which has appreciated by approximately 1.75% month-to-date. Historically, a weaker dollar has aided earnings in outperforming estimates.
• Future Outlook for the Dollar: The speaker expresses uncertainty about the dollar's continued strength. While a sustained rise could negatively impact future earnings, the speaker anticipates continued downward pressure on the dollar heading into 2026 due to deficit issues. Additionally, potential hearings regarding the constitutionality of tariffs later in the year could also exert pressure on the dollar.

Conclusion

The overarching message emphasizes the importance of disciplined investing, with a keen eye on valuation, even amidst strong market momentum. Agilent Technologies is presented as a promising pick, leveraging its strong business model and the historical outperformance of the healthcare sector during midterm election years, with potential tailwinds from improving US-China trade relations, the end of government shutdowns, and a healthier labor market. Gold is reiterated as a crucial component for portfolio diversification, and while current earnings are strong, the long-term outlook for the US dollar is viewed with caution due to persistent deficit concerns.